Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CERS · against 449 other Healthcare companies of similar size
Ranked #398 of 450 · scores higher than 12% of peers · safety percentile 12
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)37 peers with a safety percentile of 10–19, including CERS · Click a bar to see the companies
Mainly because of its beta, debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 417 reported | 1.09× | 0.17× | 11% | 33% | |
| BetaLower is better · 431 reported | 1.85 | 0.43 | 6% | 33% | |
| Current ratioHigher is better · 443 reported | 1.83× | 2.89× | 33% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 394 | 1.1B CAD (≈$774M) | 14 | 53 | |
| 395 | 19.8B INR (≈$238M) | 14 | 37 | |
| 396 | 3.6B CNY (≈$507M) | 13 | 29 | |
| 397 | 302M USD | 13 | 17 | |
| 398 | 472M USD | 12 | 33 | |
| 399 | 1.9B CNY (≈$270M) | 12 | 17 | |
| 400 | 439M EUR (≈$482M) | 11 | 46 | |
| 401 | 427M USD | 11 | 7 | |
| 402 | 487M USD | 11 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score